Lise Paquet1, Lisa Simmonds2, Charles Yang2, Shailendra Verma2. 1. Department of Psychology, Carleton University, Ottawa K1S 5B6, Canada. Electronic address: lpaquet@carleton.ca. 2. Medical Oncology, The Ottawa Hospital Cancer Centre, Ottawa, Canada.
Abstract
OBJECTIVES: 1) To describe how women at high-risk for breast cancer (BC) perceive their at-risk status and the options available to manage this risk, before and after risk counselling; 2) to explore the contributions of pre-counselling demographic, clinical, cognitive and emotional factors to post-counselling risk management intentions. METHODS: 58 of 173 eligible patients (34%) enrolled and were asked to fill surveys including measures of 1) subjective risk, 2) illness (being at high-risk for BC) and 3) treatment (surveillance, lifestyle modifications, and chemoprevention) cognitions, 4) BC fear and 5) future risk management intentions, prior to and 3 months after risk consultation. RESULTS: 48 of 58 participants (83%) completed both surveys. Beliefs and emotions about their condition and its management were stable over time. Surveillance and lifestyle were associated with stronger intentions, higher perceived need, and lower concerns than chemoprevention (all ps <0.001). The strongest predictors of intentions strengths were the women's beliefs about the risk reduction methods, especially for lifestyle and chemoprevention (all ps <0.01). CONCLUSIONS: The findings emphasize the importance of patients' beliefs in risk management decisions. PRACTICAL IMPLICATIONS: Patients' treatment beliefs appear to influence their choice of BC risk reduction strategies and should be discussed during risk reduction consultations.
OBJECTIVES: 1) To describe how women at high-risk for breast cancer (BC) perceive their at-risk status and the options available to manage this risk, before and after risk counselling; 2) to explore the contributions of pre-counselling demographic, clinical, cognitive and emotional factors to post-counselling risk management intentions. METHODS: 58 of 173 eligible patients (34%) enrolled and were asked to fill surveys including measures of 1) subjective risk, 2) illness (being at high-risk for BC) and 3) treatment (surveillance, lifestyle modifications, and chemoprevention) cognitions, 4) BC fear and 5) future risk management intentions, prior to and 3 months after risk consultation. RESULTS: 48 of 58 participants (83%) completed both surveys. Beliefs and emotions about their condition and its management were stable over time. Surveillance and lifestyle were associated with stronger intentions, higher perceived need, and lower concerns than chemoprevention (all ps <0.001). The strongest predictors of intentions strengths were the women's beliefs about the risk reduction methods, especially for lifestyle and chemoprevention (all ps <0.01). CONCLUSIONS: The findings emphasize the importance of patients' beliefs in risk management decisions. PRACTICAL IMPLICATIONS: Patients' treatment beliefs appear to influence their choice of BC risk reduction strategies and should be discussed during risk reduction consultations.
Authors: Christine M Gunn; Barbara G Bokhour; Victoria A Parker; Tracy A Battaglia; Patricia A Parker; Angela Fagerlin; Worta McCaskill-Stevens; Hanna Bandos; Sarah B Blakeslee; Christine Holmberg Journal: Med Decis Making Date: 2019-02-25 Impact factor: 2.583
Authors: Sarah B Blakeslee; Worta McCaskill-Stevens; Patricia A Parker; Christine M Gunn; Hanna Bandos; Therese B Bevers; Tracy A Battaglia; Angela Fagerlin; Jacqueline Müller-Nordhorn; Christine Holmberg Journal: Patient Educ Couns Date: 2017-06-27
Authors: Whitney Espinel; Marjan Champine; Heather Hampel; Joanne Jeter; Kevin Sweet; Robert Pilarski; Rachel Pearlman; Kate Shane; Pamela Brock; Judith A Westman; Lindsay Kipnis; Jilliane Sotelo; Anu Chittenden; Samantha Culver; Jill E Stopfer; Katherine A Schneider; Rosalba Sacca; Diane R Koeller; Shraddha Gaonkar; Erica Vaccari; Sarah Kane; Scott T Michalski; Shan Yang; Sarah M Nielsen; Sara L Bristow; Stephen E Lincoln; Robert L Nussbaum; Edward D Esplin Journal: Cancers (Basel) Date: 2022-05-13 Impact factor: 6.575
Authors: Christine Holmberg; Hanna Bandos; Angela Fagerlin; Therese B Bevers; Tracy A Battaglia; D Lawrence Wickerham; Worta J McCaskill-Stevens Journal: Cancer Prev Res (Phila) Date: 2017-10-04